EGM

Publication of Circular and Notice of Requisitioned EGM

Retrieved on: 
Monday, January 8, 2024
Risk, Audit committee, Notice, Requisition, Management, Procedure, CFO, AGM, Form, Dragon (magazine), Dragon, ALL, EGM, Limited, Hand, Chair, UK Corporate Governance Code, Prejudice, Environment, BEST, Sale, Computershare, Circular, Acquisition, Completion

The Notice of Extraordinary General Meeting sets out the resolutions to be proposed at the Requisitioned EGM (the “Vision Resolutions”) and is contained in the Circular.

Key Points: 
  • The Notice of Extraordinary General Meeting sets out the resolutions to be proposed at the Requisitioned EGM (the “Vision Resolutions”) and is contained in the Circular.
  • THE BOARD OF I-RES UNANIMOUSLY RECOMMENDS THAT SHAREHOLDERS VOTE AGAINST ALL Vision RESOLUTIONS AT THE REQUISITIONED EGM.
  • Shareholders are also invited to submit their votes in respect of the Vision Resolutions to be put to Shareholders at the Requisitioned EGM through any other means described in the Circular.
  • Details of how to do this are provided in the Statement of Procedures to the Notice of Extraordinary General Meeting set out in the Circular.

Commencement of Strategic Review

Retrieved on: 
Monday, January 8, 2024
ACT, MAKE, NAV, FIRM, IRISH, EGM, Sale, IRES, NOT, Committee, Dragon (magazine), REIT, Requisition, Dragon, AN, LAWS

The Company today announces that the Board of Directors of I-RES (the “Board”) has decided to commence a strategic review to consider and evaluate all strategic options that may be available to maximise and unlock value for shareholders in the Company (the “Strategic Review”).

Key Points: 
  • The Company today announces that the Board of Directors of I-RES (the “Board”) has decided to commence a strategic review to consider and evaluate all strategic options that may be available to maximise and unlock value for shareholders in the Company (the “Strategic Review”).
  • This Strategic Review will commence as soon as practicable in Q1 2024, following the release of the Company’s 2023 Full Year Financial Results.
  • The Special Committee will retain specialist international financial and real estate advice to assist with the Strategic Review.
  • There is no certainty that any change will result from the Strategic Review or that any sale, strategic investment or other transaction will be concluded, nor as to the terms on which any offer, strategic investment or other transaction may be made.

Hollysys Announces Shareholder Meeting to Vote on Acquisition by Ascendent Capital Partners

Retrieved on: 
Friday, January 5, 2024
Davis Polk, EGM, Sale, Acquisition, Committee, Mergers and acquisitions, Person, Automation, Memorandum, Proxy, Special, Security (finance)

BEIJING, Jan. 5, 2024 /PRNewswire/ -- Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) ("Hollysys" or the "Company") today announced that it will hold an extraordinary general meeting (the "EGM") of shareholders on Thursday, February 8, 2024 at 10:00 a.m. Hong Kong time, to consider and vote on, among other things, the proposal to authorize and approve the previously announced merger agreement (the "Merger Agreement") pursuant to which a buyer controlled by Ascendent Capital Partners ("Ascendent"), an international private investment firm headquartered in Hong Kong, will acquire all outstanding shares of Hollysys that it does not currently own for US$26.50 per share in cash.

Key Points: 
  • Over the course of several months, the Special Committee conducted an extensive and competitive process and received several competing proposals to acquire the Company.
  • On December 11, 2023, the Company announced an agreement to be acquired by Ascendent for US$26.50 per share.
  • During a "go-shop" period provided for in the Merger Agreement, the Company solicited and encouraged other acquisition proposals.
  • In addition, the Company's proxy materials, including the proxy statement, will be mailed to the shareholders of the Company.

Tarena to Hold an Extraordinary General Meeting on February 20, 2024

Retrieved on: 
Tuesday, January 2, 2024
ADS, Conference, EGM, STEAM, Date, Republic, Name, Mass meeting, Exercise, Security (finance)

BEIJING, Jan. 2, 2024 /PRNewswire/ -- Tarena International, Inc. (NASDAQ: TEDU) ("Tarena" or the "Company"), a leading provider of IT professional education and IT-focused supplementary STEAM education services in China, today announced that it will hold an Extraordinary General Meeting of Shareholders (the "EGM") at Conference Room 1, 6/F, No.

Key Points: 
  • BEIJING, Jan. 2, 2024 /PRNewswire/ -- Tarena International, Inc. (NASDAQ: TEDU) ("Tarena" or the "Company"), a leading provider of IT professional education and IT-focused supplementary STEAM education services in China, today announced that it will hold an Extraordinary General Meeting of Shareholders (the "EGM") at Conference Room 1, 6/F, No.
  • 1 Andingmenwai Street, Litchi Tower, Chaoyang District, Beijing 100011, People's Republic of China, on February 20, 2024 at 10:00 am (Beijing time).
  • The proposed name change will not affect any rights of shareholders or the Company's operations and financial position.
  • The Notice of EGM and form of proxy for the EGM are available on the Company's website at https://ir.tedu.cn .

Varia Reports Strong Q2 FY2024 Results, with Revenue up 156% to RM20.47 Million

Retrieved on: 
Thursday, November 23, 2023
PBT, EGM, Acquisition, Medical City, UPM, Growth, PTM, Pharmaceutical industry

In Q2 FY2024, Varia Berhad recorded a substantial increase in revenue and profit.

Key Points: 
  • In Q2 FY2024, Varia Berhad recorded a substantial increase in revenue and profit.
  • Revenue surged by 156% to RM20.47 million, with a profit before tax (PBT) of RM1.24 million, representing an impressive turnaround from the previous year's loss in the same quarter.
  • Over the first six months of FY2024, Varia Berhad achieved a revenue of RM40.42 million and a PBT of RM1.43 million, representing a 124% and 145% increase respectively compared to the corresponding period in the previous year.
  • As at 23 November 2023, 5:00 P.M., Varia Berhad?s share price is RM1.04 with a market capitalisation of RM70.0 million.

Kitchen Culture: Update on Progress towards Resumption of Trading of the Company's Shares

Retrieved on: 
Friday, November 17, 2023
Telephone, Trust, EGM, Sale, Robinson Road, Lung compliance, S.A.C. Capital Advisors, Sponsor, Catalist, SGX, Accounting, Culture, ACRA, Audit

This is a significant and necessary step forward in getting the Company back on the path of accountability, restoration?and fulfilling all its statutory responsibilities to shareholders."

Key Points: 
  • This is a significant and necessary step forward in getting the Company back on the path of accountability, restoration?and fulfilling all its statutory responsibilities to shareholders."
  • "Holding the EGM marks a vital milestone towards the Board's ultimate goal of obtaining SGX approval for the resumption of trading of the Company's shares.
  • Since 12 July 2021, the Company's shares have been suspended due to a variety of issues including non-compliance and systemic internal failures.
  • Ltd. by the end of the year, in compliance with statutory requirements, and is another key factor in the resumption of trading of the Company's shares.

Shareholders approve the sale of Evolva AG to Lallemand Inc. Swiss subsidiary at extraordinary general meeting

Retrieved on: 
Saturday, December 30, 2023
Marketing, EGM, Sale, SIX Swiss Exchange, Person, Approval, Amendment, Beat, Bacteria, Dissolution, Holding company

Shareholders approve the sale of Evolva AG to Lallemand Inc. Swiss subsidiary at extraordinary general meeting

Key Points: 
  • Shareholders approve the sale of Evolva AG to Lallemand Inc. Swiss subsidiary at extraordinary general meeting
    Shareholders approve the sale of Evolva AG to Lallemand Inc. Swiss subsidiary at extraordinary general meeting
    Reinach, 21 December 2023 — The shareholders of Evolva Holding SA (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, approved all the proposals put forward by the Board of Directors at today’s extraordinary general meeting (EGM).
  • The shareholders approved with large majorities (see details below) all proposals put forward by the Board of Directors: In particular, the sale by Evolva Holding SA of Evolva AG to Danstar Ferment AG, a Swiss affiliate of Lallemand Inc., was approved which secures the future of Evolva’s operations.
  • We would like to thank the Evolva shareholders for their support in securing the future of Evolva AG’s operations.”
    The convocation of an EGM became necessary after Evolva Holding SA signed, on 20 November 2023, a share purchase agreement with Danstar Ferment AG regarding the sale of all shares in Evolva Holding SA’s wholly owned subsidiary Evolva AG.
  • Agenda item 5 (Delisting of Evolva Holding SA from SIX Swiss Exchange): with 91.10% of the votes represented (votes represented: 3,052,011 votes of the total outstanding shares/votes of 6,827,012).

Valneva Shareholders Approve EGM Resolutions Including the Transition to a Board of Directors

Retrieved on: 
Wednesday, December 20, 2023
MSD, Sanofi Pasteur, Trust, EGM, Euronext Paris, Saint-Herblain, Executive Committee, Annual general meeting, Supervision, General counsel, Management, Supervisory board, VLA

These included the immediate transition from the Company’s two-tier governance model to a one-tier model led by a Board of Directors.

Key Points: 
  • These included the immediate transition from the Company’s two-tier governance model to a one-tier model led by a Board of Directors.
  • During a constitutional post-EGM meeting, Valneva’s former Supervisory Board member Anne-Marie Graffin was elected as Chair of the Company’s new Board of Directors.
  • Ms. Graffin is Vice Chair of Nanobiotix’s Supervisory Board, member of the Sartorius Stedim Biotech Board of Directors and member of Vetoquinol S.A Board of Directors.
  • Anne-Marie Graffin, Chair of Valneva´s Board of Directors, commented, “I would like to thank all departing Supervisory Board members for their contributions and the newly elected Board of Directors members for their trust.

Addex Shareholders Approve All Resolutions at Extraordinary General Meeting

Retrieved on: 
Wednesday, December 20, 2023
EGM

Ad Hoc Announcement Pursuant to Art.

Key Points: 
  • Ad Hoc Announcement Pursuant to Art.
  • 53 LR
    Geneva, Switzerland, December 20, 2023 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development (“the Company”), announced today that its shareholders approved, with a large majority, all of the proposals of the board of directors at its Extraordinary General Meeting (EGM) held on December 19, 2023.
  • The votes represented 30.07% of the Company's outstanding capital.
  • Addex shareholders approved an increase in the capital band and the conditional share capital, and related amendments to the Articles of Association.

LIZHI INC. to Hold an Extraordinary General Meeting on January 25, 2024

Retrieved on: 
Thursday, December 14, 2023
EGM, Date, Name, Mass meeting, Security (finance), Exercise

GUANGZHOU, China, Dec. 14, 2023 (GLOBE NEWSWIRE) -- LIZHI INC. (“LIZHI” or the “Company”) (NASDAQ: LIZI), an audio-based social and entertainment platform, today announced that it will hold an Extraordinary General Meeting of Shareholders (the “EGM”) at 60 Anson Road, Mapletree Anson, #09-01/02, Singapore 079914, at 2:00 pm (Singapore time) on January 25, 2024.

Key Points: 
  • GUANGZHOU, China, Dec. 14, 2023 (GLOBE NEWSWIRE) -- LIZHI INC. (“LIZHI” or the “Company”) (NASDAQ: LIZI), an audio-based social and entertainment platform, today announced that it will hold an Extraordinary General Meeting of Shareholders (the “EGM”) at 60 Anson Road, Mapletree Anson, #09-01/02, Singapore 079914, at 2:00 pm (Singapore time) on January 25, 2024.
  • The purpose of the EGM is for the Company’s shareholders to consider and, if thought fit, approve the change of the Company’s legal name from “LIZHI INC.” to “Sound Group Inc.” The proposed name change will not affect shareholders’ rights, the Company’s operations, or its financial position.
  • The board of directors of the Company has fixed the close of business on December 22, 2023, as the record date (the “Record Date”) in order to determine the shareholders entitled to receive notice of the EGM or any adjourned or postponed meeting thereof.
  • Holders of the Company’s American depositary shares (“ADSs”) who wish to exercise their voting rights for the underlying shares must act through Deutsche Bank Trust Company Americas, the depositary of the Company’s ADS program.